skip to log on skip to main content
VoiceOver users please use the tab key when navigating expanded menus
Article related to:


COVID & China’s policy choice

Chief Economist Greater China & Senior China Strategist, ANZ

2022-01-11 00:00

The current coronavirus resurgence in China presents a downside risk to the country’s economic recovery due to stricter containment measures amid the government’s zero-tolerance approach.

The risk of virus contagion in China looms, as seen in the latest data from China’s National Health Commission. The city of Xuchang has reported a spike in cases. There have also been cases reported in other cities across the same province, including Zhengzhou, Luoyang and Zhoukou. At the same time, the situation in Xi’an seems to be improving as new cases dipped compared to end December.

China’s port of Ningbo, the third-busiest in the world, is facing disruptions due to truck entry restrictions and suspended freight operations, on the back of roadblocks in other parts of the city.

These delays and backlogs could exacerbate the inflation in shipping costs as well as exert pressure on export volumes. However, China is unlikely to budge from its current stance.

Previous infection clusters in the provinces of Jiangsu and Hebei were terminated after 30 to 40 days of mobility curbs and lockdowns, reinforcing belief in the effectiveness of such measures. It is likely China will maintain its stance at least until the Beijing Winter Olympics are completed in late February.

However, there are trade-offs as the current zero-tolerance measures require China to lift its countercyclical economic policy stance. The jobless rate may continue to rise in the coming weeks.

The employment sub-index in the non-manufacturing PMI registered its worst performance in the final quarter of calendar 2021. In addition to monetary policy easing, Premier Li Keqiang has pledged to intensify the implementation of tax and fee cuts to ease pressures on Chinese businesses.

In ANZ Research’s view, the overall policy direction has shifted to growth stabilisation. Given the latest COVID outbreak, further policy support is expected.

Raymond Yeung is Chief Economist Greater China & Zhaopeng Xing is a Senior China Strategist at ANZ

This is an edited excerpt from the ANZ Research report ‘China: tough trade-offs in the fight against COVID-19’, published January 6, 2022. Click to read the full document.

COVID & China’s policy choice
Raymond Yeung & Zhaopeng Xing
Chief Economist Greater China & Senior China Strategist, ANZ

Related articles

  • China

    China leans into green

    Betty Wang & Soni Kumari Senior China Economist & Commodity Strategist, ANZ Institutional

    China’s carbon-neutrality plan has wide-ranging impacts for green investment, which could reach 13 trillion renminbi in size.

    2022-07-20 00:00
  • China

    China’s growth options

    Betty Wang, Zhaopeng Xing & Raymond Yeung Senior China Economist, Senior China Strategist & Chief Economist, China at ANZ

    Recent better-than-expected data fails to ease market concerns. Further measures will be required to address underlying growth issues.

    2022-04-28 00:00

This publication is published by Australia and New Zealand Banking Group Limited ABN 11 005 357 522 (“ANZBGL”) in Australia. This publication is intended as thought-leadership material. It is not published with the intention of providing any direct or indirect recommendations relating to any financial product, asset class or trading strategy. The information in this publication is not intended to influence any person to make a decision in relation to a financial product or class of financial products. It is general in nature and does not take account of the circumstances of any individual or class of individuals. Nothing in this publication constitutes a recommendation, solicitation or offer by ANZBGL or its branches or subsidiaries (collectively “ANZ”) to you to acquire a product or service, or an offer by ANZ to provide you with other products or services. All information contained in this publication is based on information available at the time of publication. While this publication has been prepared in good faith, no representation, warranty, assurance or undertaking is or will be made, and no responsibility or liability is or will be accepted by ANZ in relation to the accuracy or completeness of this publication or the use of information contained in this publication. ANZ does not provide any financial, investment, legal or taxation advice in connection with this publication.